GLIA-CTN: Exploring Potential Biomarkers for Alexander Disease
Iscriviti gratuitamente
Ascolta questo episodio e molti altri. Goditi i migliori podcast su Spreaker!
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
29 mag 2024 ·
1 min. 31 sec.
New research from the Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN). This summary is based on a paper published in the journal Neurological Sciences on April 1, 2024, titled "Plasma...
mostra di più
New research from the Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN). This summary is based on a paper published in the journal Neurological Sciences on April 1, 2024, titled "Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease."
Read the paper here: https://link.springer.com/article/10.1007/s10072-024-07495-8
Learn more about GLIA-CTN: https://glia-ctn.rarediseasesnetwork.org
mostra meno
Read the paper here: https://link.springer.com/article/10.1007/s10072-024-07495-8
Learn more about GLIA-CTN: https://glia-ctn.rarediseasesnetwork.org
Informazioni
| Autore | RDCRN |
| Sito | - |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
